API | live attenuated chimeric japanese encephalitis vaccine

live attenuated chimeric japanese encephalitis vaccine Report issue

Vaccine Experimental

AACT

Active Ingredient History

NOW

Now

Chemistry

SMILES: Missing data
InChIKey: Missing data
Mol. Mass: Missing data
ALogP: Missing data
ChEMBL Molecules: Missing data

More Chemistry

Pharmacology

Mechanism of Action:
Multi-specific: Missing data
Black Box: Missing data
Availability: Missing data
Delivery Methods: Missing data
Pro Drug: Missing data

attenuated japanese encephalitis virus | imojev | japanese encephalitis live attenuated sa 14-14-2 vaccine | je live attenuated sa 14-14-2 vaccine | live attenuated chimeric japanese encephalitis vaccine | live attenuated chimeric je vaccine | live attenuated japanese encephalitis chimeric virus vaccine | live attenuated japanese encephalitis vaccine sa14-14-2 | live attenuated japanese encephalitis virus | live attenuated je vaccine | live attenuated sa 14-14-2 vaccine

Organizations (17)

Research & Development (17)

Organization	Org Type	FDA approvals	Clinical Trials involvement	Org ID	Force Sort

Marketing (0)

Organization	Org Type	FDA approvals	Clinical Trials involvement	Org ID	Force Sort

Indications (8)

Approved Indications (1)

Encephalitis, Japanese

Experimental Indications - Clinical Trial Phases 1-4 (8)

Chickenpox (Phase 4)

Communicable Diseases (Phase 2)

Encephalitis (Phase 4)

Encephalitis, Japanese (Phase 4)

Hand, Foot and Mouth Disease (Phase 4)

Japanese Encephalitis Vaccines (Phase 4)

Virus Diseases (Phase 2)

Yellow Fever (Phase 2)

Overview

Highest Phase: Phase 4
# of Trials: 21
# of Trial Organizations: 17

Trials by Phase

Trial	Phase	Start Date	Organizations	Indications

Feedback

Data collection and curation is an ongoing process for CDEK - if you notice any information here to be missing or incorrect, please let us know! When possible, please include a source URL (we verify all data prior to inclusion).

Report issue